Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus

Journal of Pathology

Volumn 190, Issue 2, 2000, Pages 177-183

  van Sandick, Johanna W ^a   Baak, Jan P A ^b   van Lanschot, J Jan B ^a   Polkowski, Wojciech ^a   ten Kate, Fiebo J W ^a   Obertop, Hugo ^a   Offerhaus, G Johan A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Location Alkmaar   (Netherlands)

Author keywords

Barrett's oesophagus; Immunohistochemistry; Ki67; Morphometry; P53

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ARTICLE; BARRETT ESOPHAGUS; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLUMNAR EPITHELIUM; COMPUTER ANALYSIS; DYSPLASIA; ESOPHAGUS BIOPSY; ESOPHAGUS RESECTION; HUMAN; HUMAN TISSUE; MORPHOMETRICS; PRIORITY JOURNAL; QUANTITATIVE HISTOCHEMISTRY;

BARRETT ESOPHAGUS; BIOPSY; ESOPHAGEAL NEOPLASMS; FEASIBILITY STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KI-67 ANTIGEN; NEOPLASM PROTEINS; OBSERVER VARIATION; PRECANCEROUS CONDITIONS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033952888     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(200002)190:2<177::AID-PATH508>3.0.CO;2-X     Document Type: Article

References (30)

1. Spechler SJ, Goyal RK. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996; 110: 614-621.
2. Stein HJ. Esophageal cancer: screening and surveillance. Results of a consensus conference held at the VIth World Congress of the International Society for Diseases of the Esophagus. Dis Esoph 1996; 9: S3-S19.
3. van Sandick JW, van Lanschot JJB, Kuiken BW, et al. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998; 43: 216-222.
4. Edwards MJ, Gable DR, Lentsch AB, Richardson JD. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg 1996; 223: 585-591.
5. Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett's oesophagus. Hum Pathol 1988; 19: 166-178.
6. Sagan Ch, Fléjou JF, Diebold MD, Potet F, Le Bodic MF. Reproducibilité des critères histologiques de dysplasie sur muqueuse de Barrett. Gastroenterol Clin Biol 1994; 18: D31-D34.
7. Jarvis LR, Whitehead R. Morphometric analysis of gastric dysplasia. J Pathol 1985; 147: 133-138.
8. Tosi P, Luzi P, Baak JPA. Gastric dysplasia: a stereological and morphometrical assessment. J Pathol 1987; 152: 83-94.
9. Meijer GA, Meuwissen SGM, Baak JPA. Classification of colorectal adenomas with quantitative pathology. Evaluation of morphometry, stereology, mitotic counts and syntactic structure analysis. Anal Cell Pathol 1995; 9: 311-323.
10. Hamilton PW, Thompson D, Sloan JM, Bartels PH. Knowledge-guided segmentation and morphometric analysis of colorectal dysplasia. Anal Quant Cytol Histol 1995; 17: 172-182.
11. Baak JPA, Oort J, Fleege JC, van Diest PJ, Ploem JS. Techniques in quantitative pathology. In Manual of Quantitative Pathology in Cancer Diagnosis and Prognosis, Baak JPA (ed). Springer-Verlag: Berlin, 1991; 45-56.
12. Polkowski W, van Lanschot JJB, ten Kate FJW. et al. The value of p53 and Ki67 as markers for tumor progression in the Barrett dysplasia-carcinoma sequence. Surg Oncol 1995; 4: 163-171.
13. Polkowski W, Baak JPA, van Lanschot JJB, et al. Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation. J Pathol 1998; 184: 161-168.
14. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983; 14: 931-968.
15. Hamilton SR. Adenocarcinoma in Barrett's oesophagus. In Gastrointestinal and Oesophageal Pathology, Whitehead R (ed). Churchill Livingstone: Edinburgh, 1989; 683-700.
16. Baas IO, Mulder JWR, Offerhaus GJA, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994; 172: 5-12.
17. Rose DSC, Maddox PH, Brown DC. Which proliferation markers for routine immunohistology? A comparison of five antibodies. J Clin Pathol 1994; 47: 1010-1014.
18. Polkowski W, Meijer GA, Baak JPA, et al. Reproducibility of p53 and Ki67 immunoquantitation in Barrett's oesophagus. Anal Quant Cytol Histol 1997; 19: 246-254.
19. Fleege JC, van Diest PJ, Baak JPA. Systematic random sampling for selective interactive nuclear morphometry in breast cancer sections. Anal Quant Cytol Histol 1997; 15: 281-289.
20. Sørensen FB, Ottosen PD. Stereological estimation of nuclear volume in benign and malignant melanocytic lesions of the skin. Inter- and intra-observer variability of malignancy grading. Am J Dermatopathol 1991; 13: 99-107.
21. Fleege JC, van Diest PJ, Baak JPA. Reliability of quantitative pathological assessments, standards, and quality control. In Manual of Quantitative Pathology in Cancer Diagnosis and Prognosis, Baak JPA (ed). Springer-Verlag: Berlin, 1991; 169-172.
22. Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992; 102: 1212-1219.
23. Van Diest PJ, Smeulders AW, Thunnissen FB, Baak JP. Cytomorphometry. A methodologic study of preparation techniques, selection methods and sample sizes. Anal Quant Cytol Histol 1989; 11: 225-231.
24. Meijer GA, Baak JPA. Cytonuclear morphometry in the assessment of dysplasia in colorectal adenomatous polyps. A pilot study. Pathol Res Pract 1992; 188: 148-156.
25. Van Diest PJ, Baak JPA, Matze-Cok P, et al. Reproducibility of mitosis counting in 2469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol 1992; 23: 603-607.
26. Jankowski J, Hopwood D, Wormsley KG. Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma. Scand J Gastroenterol 1992; 27: 147-154.
27. Ramel S, Reid BJ, Sanchez CA, et al. Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. Gastroenterology 1992; 102: 1220-1228.
28. Iftikhar SY, Steele RJC, Watson S, James PD, Dilks K, Hardcastle JD. Assessment of proliferation of squamous, Barrett's and gastric mucosa in patients with columnar lined Barrett's oesophagus. Gut 1992; 33: 733-737.
29. Hong MK, Laskin WB, Herman BE, et al. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's oesophagus. Cancer 1995; 75: 423-429.
30. Baak JPA, Langley FA, Hermans J. Classification and prognosis for new cases: some aspects of univariate and multivariate analysis. In Manual of Quantitative Pathology in Cancer Diagnosis and Prognosis, Baak JPA (ed). Springer-Verlag: Berlin, 1991; 193-194.